[HTML][HTML] Recent advances in the management of non-small cell lung cancer
S Shojaee, P Nana-Sinkam - F1000Research, 2017 - ncbi.nlm.nih.gov
Lung cancer is the number one cause of cancer-related death in both men and women.
However, over the last few years, we have witnessed improved outcomes that are largely …
However, over the last few years, we have witnessed improved outcomes that are largely …
Radiological distribution of brain metastases and its implication for the hippocampus avoidance in whole brain radiotherapy approach
YM Han, G Cai, WM Chai, C Xu, L Cao… - The British Journal of …, 2017 - academic.oup.com
Objective: Hippocampus avoidance in whole brain radiotherapy (HA-WBRT) offers the
feasibility of less-impaired cognitive function than conventional WBRT. The study aims to …
feasibility of less-impaired cognitive function than conventional WBRT. The study aims to …
Determination of AZD3759 in rat plasma and brain tissue by LC–MS/MS and its application in pharmacokinetic and brain distribution studies
S Xiong, M Xue, Y Mu, Z Deng, P Sun… - Journal of pharmaceutical …, 2017 - Elsevier
A simple and sensitive high performance liquid chromatography with tandem mass
spectrometry (LC–MS/MS) method for determination of AZD3759, a novel epidermal growth …
spectrometry (LC–MS/MS) method for determination of AZD3759, a novel epidermal growth …
Multiple treatment modalities for brain metastasis in patients with EGFR-mutant non-small-cell lung cancer
H Wang, X Yu, Y Fan, Y Jiang - OncoTargets and therapy, 2018 - Taylor & Francis
Background There are many controversies concerning the best management of epidermal
growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC) patients with …
growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC) patients with …
Screening for ALK abnormalities in central nervous system metastases of non‐small‐cell lung cancer
M Nicoś, B Jarosz, P Krawczyk… - Brain …, 2018 - Wiley Online Library
Anaplastic lymphoma kinase (ALK) gene rearrangement was reported in 3%–7% of primary
non‐small‐cell lung cancer (NSCLC) and its presence is commonly associated with …
non‐small‐cell lung cancer (NSCLC) and its presence is commonly associated with …
[HTML][HTML] Screening for gene mutations in central nervous system metastases of non‐small‐cell lung cancer
M Nicoś, P Krawczyk, B Jarosz, M Sawicki… - Brain …, 2018 - ncbi.nlm.nih.gov
Non-small-cell lung cancer (NSCLC) is characterized by aggressive clinical course
including frequent occurrence of distant metastases. Central nervous system (CNS) …
including frequent occurrence of distant metastases. Central nervous system (CNS) …
Targeted Therapies For Treatment of Lung Cancer–Recent Advances
F Khan, SS Sisodia - … and Biosciences Journal, 2020 - pharmabiosciencejournal.com
In both men and women, Lung cancer is the number one cause of cancer-related death. The
disorder is especially difficult to detect, and often develops for elderly patients at an …
disorder is especially difficult to detect, and often develops for elderly patients at an …
[PDF][PDF] Recent advances in the management of non-small cell lun g cancer [version 1; peer review: 2 approved]
S Shojaee, P Nana-Sinkam - 2017 - pdfs.semanticscholar.org
Lung cancer is the number one cause of cancer-related death in both men and women.
However, over the last few years, we have witnessed improved outcomes that are largely …
However, over the last few years, we have witnessed improved outcomes that are largely …
Recent advances in the management of non-small cell lung cancer
S Samira, NS Patrick - F1000Research, 2017 - search.proquest.com
Lung cancer is the number one cause of cancer-related death in both men and women.
However, over the last few years, we have witnessed improved outcomes that are largely …
However, over the last few years, we have witnessed improved outcomes that are largely …